Rabiet Marie-Josèphe, Huet Emilie, Boulay François
Laboratoire de Biochimie et de Biophysique des Systèmes Intégrés, CEA, CNRS, Université Joseph Fourier, Institut de Recherches en Technologies et Sciences pour le Vivant (iRTSV), Commissariat à l'Energie Atomique Grenoble, 38054 Grenoble cedex 9, France.
Biochimie. 2007 Sep;89(9):1089-106. doi: 10.1016/j.biochi.2007.02.015. Epub 2007 Mar 3.
Leukocyte recruitment to sites of inflammation and infection is dependent on the presence of a gradient of locally produced chemotactic factors. This review is focused on current knowledge about the activation and regulation of chemoattractant receptors. Emphasis is placed on the members of the N-formyl peptide receptor family, namely FPR (N-formyl peptide receptor), FPRL1 (FPR like-1) and FPRL2 (FPR like-2), and the complement fragment C5a receptors (C5aR and C5L2). Upon chemoattractant binding, the receptors transduce an activation signal through a G protein-dependent pathway, leading to biochemical responses that contribute to physiological defense against bacterial infection and tissue damage. C5aR, and the members of the FPR family that were previously thought to be restricted to phagocytes proved to have a much broader spectrum of cell expression. In addition to N-formylated peptides, numerous unrelated ligands were recently found to interact with FPR and FPRL1. Novel agonists include both pathogen- and host-derived components, and synthetic peptides. Antagonistic molecules have been identified that exhibit limited receptor specificity. How distinct ligands can both induce different biological responses and produce different modes of receptor activation and unique sets of cellular responses are discussed. Cell responses to chemoattractants are tightly regulated at the level of the receptors. This review describes in detail the regulation of receptor signalling and the multi-step process of receptor inactivation. New concepts, such as receptor oligomerization and receptor clustering, are considered. Although FPR, FPRL1 and C5aR trigger similar biological functions and undergo a rapid chemoattractant-mediated phosphorylation, they appear to be differentially regulated and experience different intracellular fates.
白细胞向炎症和感染部位的募集依赖于局部产生的趋化因子梯度的存在。本综述聚焦于关于趋化因子受体激活和调控的当前知识。重点在于N-甲酰肽受体家族的成员,即FPR(N-甲酰肽受体)、FPRL1(类FPR-1)和FPRL2(类FPR-2),以及补体片段C5a受体(C5aR和C5L2)。趋化因子结合后,这些受体通过G蛋白依赖性途径转导激活信号,引发有助于抵御细菌感染和组织损伤的生理防御的生化反应。C5aR以及先前被认为仅限于吞噬细胞的FPR家族成员,其细胞表达谱要广泛得多。除了N-甲酰化肽,最近还发现许多不相关的配体与FPR和FPRL1相互作用。新型激动剂包括病原体和宿主来源的成分以及合成肽。已鉴定出具有有限受体特异性的拮抗分子。本文讨论了不同配体如何既能诱导不同的生物学反应,又能产生不同的受体激活模式和独特的细胞反应集。细胞对趋化因子的反应在受体水平受到严格调控。本综述详细描述了受体信号传导的调控以及受体失活的多步骤过程。还考虑了诸如受体寡聚化和受体聚集等新概念。尽管FPR、FPRL1和C5aR触发相似的生物学功能并经历快速的趋化因子介导的磷酸化,但它们似乎受到不同的调控并经历不同的细胞内命运。